Full Name
Sunny Singh
Job Title
Gastroenterologist
Company/Institution/ Organization
West Coast Gastroenterology
Speaker Bio
Dr. Singh is a Gastroenterologist with a special interest in the Inflammatory Bowel Diseases.
Dr. Singh completed his undergraduate Bachelor of Science at the University of Winnipeg. He then attended the University of Manitoba to complete his Bachelor of Science in Medicine and his Medical Degree. Subsequently, he completed his Internal Medicine residency at the University of Alberta, followed by his Gastroenterology fellowship at the University of Calgary. He then pursued an Advanced Inflammatory Bowel Disease Fellowship at the University of Calgary before his arrival in Kelowna to join the Kelowna Gastroenterology Associates. He practised here for 9 years before accepting a position at Vancouver General Hospital to help run the IBD clinic.
Dr. Singh has research interests in IBD surgical outcomes, IBD epidemiology and IBD risk factors and has published research within various recognized Gastroenterology journals including the American Journal of Gastroenterology, Clinical Gastroenterology & Hepatology and Gastroenterology. He now continues his research with clinical trials including evaluation of novel biologic therapeutic targets and long term safety profiles for biologics.
Dr. Singh completed his undergraduate Bachelor of Science at the University of Winnipeg. He then attended the University of Manitoba to complete his Bachelor of Science in Medicine and his Medical Degree. Subsequently, he completed his Internal Medicine residency at the University of Alberta, followed by his Gastroenterology fellowship at the University of Calgary. He then pursued an Advanced Inflammatory Bowel Disease Fellowship at the University of Calgary before his arrival in Kelowna to join the Kelowna Gastroenterology Associates. He practised here for 9 years before accepting a position at Vancouver General Hospital to help run the IBD clinic.
Dr. Singh has research interests in IBD surgical outcomes, IBD epidemiology and IBD risk factors and has published research within various recognized Gastroenterology journals including the American Journal of Gastroenterology, Clinical Gastroenterology & Hepatology and Gastroenterology. He now continues his research with clinical trials including evaluation of novel biologic therapeutic targets and long term safety profiles for biologics.
Speaking At
